CytomX Therapeutics (CTMX) EV to CFO (2017 - 2021)
CytomX Therapeutics' (CTMX) EV to CFO stood at 4.34 in Q1 2021.
Powered by 
Analysis
CytomX Therapeutics (CTMX) EV to CFO (2017 - 2021) Analysis & Trends
On a TTM basis, CytomX Therapeutics' EV to CFO came in at -34.92 as of Mar 31, 2021; for FY2020, it came in at -0.01.
- Across earlier years, EV to CFO came in at 2.57 in FY2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | CytomX Therapeutics | 586.15 Mn | -371.52 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 4.34 |
| Dec 31, 2020 | -0.01 |
| Mar 31, 2018 | 4.26 |
| Dec 31, 2017 | 2.57 |
| Sep 30, 2017 | 2.28 |
| Jun 30, 2017 | 1.66 |
API Access
CytomX Therapeutics EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();